Warfarin effectively prevents stroke in patients with atrial fibrillation but has a narrow therapeutic window with an increased risk of stroke and bleeding when above or below the time in therapeutic range (TTR) of international normalized ratio of 2.0 to 3.0. There are large variations of TTR across individuals, sites, and countries, which are related to patient outcomes. The global Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARIS-TOTLE) trial randomized 18 201 patients with atrial fibrillation in 1034 centers in 39 countries to apixaban or warfarin at a median TTR of 66% but with substantial variation between countries, centers, and patients. The overall results showed that apixaban reduced stroke by 21%, death by 11%, and major bleeding by 31%. Key additional questions involved the extent of benefits that remained in centers with higher TTR. The challenge in determining this issue is the lack of a comparable measure of the level of anticoagulation in both the apixaban and warfarin arms. We developed a new method in which, for each patient, a center average TTR was estimated with the use of a linear mixed model based on real TTRs in the warfarin-treated patients, with a fixed effect for country and random effect for center. For each patient, an individual TTR was also predicted with the use of a linear mixed effects model including patient characteristics as well. The results of these analyses consistently showed that the benefits of apixaban compared with warfarin for stroke or systemic embolism, bleeding, and mortality appeared similar across the range of centers' and patients' predicted quality of international normalized ratio control. See p 2166.
Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease
The 2011 American College of Cardiology Foundation/ American Heart Association revascularization guidelines have assigned a Class IIa recommendation ("should be considered") to percutaneous coronary intervention (PCI) to improve survival over medical therapy in selected patients with unprotected left main coronary artery disease, yet no trials have directly compared PCI with medical therapy for patients with this condition. We used traditional frequentist statistical approaches and bayesian methods to analyze the 7 trials comparing coronary artery bypass graft surgery with medical therapy and 12 clinical trials comparing coronary artery bypass graft with PCI for patients with unprotected left main coronary artery disease. The odds ratio (OR) for 1-year mortality after PCI versus coronary artery bypass graft using bayesian meta-analysis (posterior median OR, 1.04, 95% bayesian credible interval [BCI], 0.74-1.39) was not different from the OR using frequentist random-effects meta-analysis (OR, 1.00; 95% confidence interval, 0.72-1.40). A bayesian cross-design analysis suggested that the primary outcomes were similar for randomized clinical trials (OR, 0.99; 95% BCI, 0.67-1.43), matched cohort studies (OR, 1.10; 95% BCI, 0.76-1.73), and other types of cohort studies (OR, 0.93; 95% BCI, 0.58-1.35). A bayesian network meta-analysis suggested that medical therapy alone is associated with a higher 1-year mortality than PCI for patients with unprotected left main coronary artery disease (OR, 3.22; 95% BCI, 1.96-5.30). Bayesian methods support the current revascularization guidelines and suggest that PCI improves survival over medical therapy alone for patients with unprotected left main coronary artery disease. An integrated approach using both frequentist and bayesian methods may yield new insights to enhance the translation of trial data into clinical practice. See p 2177.
Should Bilateral Internal Thoracic Artery Grafting Be Used in Elderly Patients Undergoing Coronary Artery Bypass Grafting?
Our study shows that long-term survival after bilateral internal thoracic artery (BITA) grafting with the skeletonization technique is good for all age groups (≤65, 65-75, >75 years), approaching survival of the sex-and age-matched general population. Despite significantly lower long-term survival in the older age group (>75 years), their survival benefit, compared with Charlson Comorbidity Index-predicted survival without surgery, was not lower than that of the younger age groups. In our opinion, BITA grafting should be considered in patients >65 years of age because of the significant survival benefit, with no increased risk of sternal infection. This observation supports increased adoption of BITA grafting in the elderly, who are beginning to constitute a large proportion of the patients referred today for coronary artery bypass grafting. A major concern of surgeons that discourages them from the use of BITA is postoperative sternal infection, especially in elderly patients, who have poor sternal blood supply. The present study showed that the risk of sternal infection was not increased in the older age group; thus, age alone should not preclude the use of BITA. This observation is probably related to better preservation of sternal collateral blood flow with the skeletonization technique. The reduction of sternal infection occurrence in the later period of our study (2000) (2001) suggests that the use of BITA grafting should be selective and that this technique should not be used in patients with chronic obstructive pulmonary disease or in obese females who have diabetes mellitus. See p 2186.
Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has become an established treatment option for patients with symptomatic severe aortic stenosis who are deemed inoperable or at a high risk for perioperative mortality. Clinical and subclinical cerebrovascular events appear to be more frequent after TAVR in comparison with surgical aortic valve replacement.
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June 4, 2013 TAVR requires significant manipulation and instrumentation in the ascending aorta and especially the aortic root, which may dislodge debris and promote thrombus formation. By using a filter-based embolic protection device, which was inserted via a right radial artery entry before the start of the TAVR procedure, and by encompassing the deployment of a mesh filter in the brachiocephalic trunk and the left common carotid artery, we found that macroscopically visible debris could be captured in 75% of TAVR procedures on removal of the filters after completion of the procedure. This captured debris appeared to originate from the aortic valve leaflet or aortic wall in over one half of the cases with the presence of thrombotic material apparent in an equal amount of patients. Because TAVR technology shifts toward a lower risk and, thus, likely a younger patient population, the need to address and reduce cerebrovascular embolization becomes more urgent. Centers may therefore consider adoption of an embolic protection strategy and improved periprocedural anticoagulation protocols to reduce the cerebral burden of procedure-related valvular and thrombus-containing embolic debris. See p 2194.
Mortality and Sudden Death in Pediatric Left Ventricular Noncompaction in a Tertiary Referral Center
Left ventricular noncompaction is a cardiomyopathy characterized by excessive trabeculation of the left ventricle, progressive myocardial dysfunction, and early mortality. There remains great interest in characterizing the natural history of this disease to help guide counseling and management of what is known to be a heterogeneous patient population. Current understanding of the natural history of left ventricular noncompaction is restricted to several case series and small studies. Although arrhythmias and sudden death have been reported, our understanding of mortality profiles in left ventricular noncompaction remains limited. This retrospective review of all children diagnosed with isolated left ventricular noncompaction at a single tertiary referral center provides the largest analysis to date, examining the mortality profiles and the incidence of arrhythmias and sudden cardiac death in this patient population. See p 2202.
Interactions Between Vascular Wall and Perivascular Adipose Tissue Reveal Novel Roles for Adiponectin in the Regulation of Endothelial Nitric Oxide Synthase Function in Human Vessels

